These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15131789)

  • 21. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).
    Han KH; Rha SW; Kang HJ; Bae JW; Choi BJ; Choi SY; Gwon HC; Bae JH; Hong BK; Choi DH; Han KR
    J Clin Lipidol; 2012; 6(4):340-51. PubMed ID: 22836071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining patient risks from expanded preventive therapies.
    Tolman KG
    Am J Cardiol; 2000 Jun; 85(12A):15E-9E. PubMed ID: 10858489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.
    Russo MW; Hoofnagle JH; Gu J; Fontana RJ; Barnhart H; Kleiner DE; Chalasani N; Bonkovsky HL
    Hepatology; 2014 Aug; 60(2):679-86. PubMed ID: 24700436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-induced hepatotoxicity.
    Kaplowitz N
    Gastroenterology; 2004 Oct; 127(4):1278; author reply 1278-9. PubMed ID: 15481021
    [No Abstract]   [Full Text] [Related]  

  • 25. Monitoring statin safety in primary care.
    Tragni E; Filippi A; Mazzaglia G; Sessa E; Cricelli C; Catapano AL
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):652-7. PubMed ID: 17300133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
    Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
    Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review.
    Bolesta S; Roslund BP
    Am J Health Syst Pharm; 2008 Jan; 65(1):37-41. PubMed ID: 18159037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
    Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
    J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone.
    Merz T; Fuller SH
    Am J Health Syst Pharm; 2007 Sep; 64(17):1818-21. PubMed ID: 17724362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction.
    Lofthus DM; Stevens SR; Armstrong PW; Granger CB; Mahaffey KW
    Coron Artery Dis; 2012 Jan; 23(1):22-30. PubMed ID: 22113063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.
    Kalantari S; Naghipour M
    Adv Biomed Res; 2014; 3():168. PubMed ID: 25221771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events of statin-fenofibric acid versus statin monotherapy: a meta-analysis of randomized controlled trials.
    Geng Q; Ren J; Chen H; Lee C; Liang W
    Curr Med Res Opin; 2013 Mar; 29(3):181-8. PubMed ID: 23323878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced liver injury associated with statins.
    Russo MW; Scobey M; Bonkovsky HL
    Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Declining frequency of liver enzyme abnormalities with statins: experience from general practice in Jerusalem.
    Kiderman A; Ben-Dov IZ; Glikberg F; Ackerman Z
    Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1002-5. PubMed ID: 18787468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of statins: effects on muscle and the liver.
    Vasudevan AR; Hamirani YS; Jones PH
    Cleve Clin J Med; 2005 Nov; 72(11):990-3, 996-1001. PubMed ID: 16315438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of statins on the liver: clinical analysis of patients with ischemic stroke.
    Zhang LS; Liu ZX; Lü W; Hu XY
    Chin Med J (Engl); 2011 Mar; 124(6):897-900. PubMed ID: 21518599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Special recommendations for lipid-lowering treatment: efficacy and safety].
    Martinez TL; Nascimento HM
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():6-8. PubMed ID: 16400389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum transaminase level changes in dengue fever and its correlation with disease severity.
    Mahmuduzzaman M; Chowdhury AS; Ghosh DK; Kabir IM; Rahman MA; Ali MS
    Mymensingh Med J; 2011 Jul; 20(3):349-55. PubMed ID: 21804492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and elevated liver tests: what's the fuss?
    Onusko E
    J Fam Pract; 2008 Jul; 57(7):449-52. PubMed ID: 18625167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum transaminases as a prognostic factor in children post cardiac surgery.
    Shteyer E; Yatsiv I; Sharkia M; Milgarter E; Granot E
    Pediatr Int; 2011 Oct; 53(5):725-728. PubMed ID: 21410598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.